SEARCH RESULTS FOR: 【溦信88931766】推特主播onlyfans【老主播2【6.36gb18v】最全所有视频资源全部作品合集.aqc(4948 results)
The Prometra Programmable Pump is a sterile, battery-operated, teardrop-shaped implantable, programmable infusion pump, with a rigid titanium housing and flow controller system, which dispenses infusate into the intrathecal space through an implanted intrathecal catheter.
Flowonix Medical, Inc.
11827
In Commercial Distribution
- 00810335020082 ()
- Implantable intrathecal infusion pump, programmable
RT3 Surgical Hemostat
Stryker Corporation
2113-0205
Not in Commercial Distribution
- 00808232001280 ()
- Total Volume: 4.5 Milliliter
2113-0205
- Collagen haemostatic agent, non-antimicrobial
RT3 Surgical Hemostat
Stryker Corporation
2113-0202
Not in Commercial Distribution
- 00808232001273 ()
- Total Volume: 2.0 Milliliter
2113-0202
- Collagen haemostatic agent, non-antimicrobial
SENSOR MMT-7020A ENLITE3 5PK 2L US
MEDTRONIC MINIMED, INC.
MMT-7020A
In Commercial Distribution
- 20643169704057 ()
- 00643169704053 ()
- Percutaneous interstitial-fluid glucose monitoring system sensor
HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen).
FIDIA FARMACEUTICI SPA
FID185704
Not in Commercial Distribution
- M71389122496630SAM1 ()
- M71389122496630SAM0 ()
- Total Volume: 3 Milliliter
FID185704
- Synovial fluid supplementation medium
HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen).
FIDIA FARMACEUTICI SPA
89122-4966-30
Not in Commercial Distribution
- M71389122496630A16 ()
- M71389122496630A ()
- Total Volume: 3 Milliliter
89122-4966-30
- Synovial fluid supplementation medium
HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals.
FIDIA FARMACEUTICI SPA
FID185704
Not in Commercial Distribution
- M71389122049663SAM1 ()
- M71389122049663SAM0 ()
- Total Volume: 3 Milliliter
FID185704
- Synovial fluid supplementation medium
HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals.
FIDIA FARMACEUTICI SPA
89122-0496-63
Not in Commercial Distribution
- M71389122049663A16 ()
- M71389122049663 ()
- Total Volume: 3 Milliliter
89122-0496-63
- Synovial fluid supplementation medium
HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking. The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals. The product is packaged in a one syringe pack.
FIDIA FARMACEUTICI SPA
89122-0496-01
In Commercial Distribution
- M713891220496010 ()
- Total Volume: 3 Milliliter
89122-0496-01
- Synovial fluid supplementation medium
Alinity m HR HPV AMP Kit
ABBOTT MOLECULAR INC.
09N15-095
In Commercial Distribution
- 00884999048614 ()
09N15-095
- Human papillomavirus (HPV) high risk strain nucleic acid IVD, kit, nucleic acid technique (NAT)